Navigation Links
Global Probiotics Council Announces First Awardees for New Young Investigator Grant for Probiotics Research
Date:7/24/2008

ALEXANDRIA, Va., July 24 /PRNewswire/ -- The Global Probiotics Council (GPC), a committee established in 2004 by Groupe DANONE and Yakult Honsha Co., Ltd., announced the two awardees who will receive the inaugural Young Investigator Grant for Probiotics Research (YIGPRO) today. The program was created to identify young rising stars who will continue to contribute to the advancement of probiotics and gut microbiota research in the United States.

Ajay S. Gulati, MD, an Assistant Professor of Pediatrics in the department of Pediatric Gastroenterology at the University of North Carolina at Chapel Hill, was selected for his research proposal, "Antimicrobial Peptide Mediated Alterations of the Gut Microbiome in Nod 2/IL-10 Deficient Mice." This research will focus on a very important mechanistic process that could help researchers understand how host immune responses control the bacterial population that lives in the gut.

The other grant will be awarded to Matthew A. Ciorba, MD who is an Instructor in Medicine in the Division of Gastroenterology at Washington University in Saint Louis. His proposal, "Probiotic Bacteria Protect from Radiation Induced Intestinal Injury: Mechanisms of Action" also scored at the top. This study could make an important contribution in understanding the mechanisms by which a probiotic may protect the intestine from cell destruction caused by radiation.

The Global Probiotics Council was pleased with the impressive quality of the applications received. A rigorous review and evaluation of all the applications was provided by the U.S. Probiotics Scientific Board Selection Committee, which is composed of W. Allan Walker, MD, Conrad Taff Professor of Nutrition at Harvard Medical School, Mary Ellen Sanders, PhD, Executive Director, International Scientific Association for Probiotics and Prebiotics (ISAPP), and Balfour Sartor, MD, Distinguished Professor of Medicine, Microbiology and Immunology, University of North Carolina
'/>"/>

SOURCE The Global Probiotics Council
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Global Experts Explore Entire Spectrum of Aids Vaccine Development
2. Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
3. Advanced Life Sciences to Present at 2007 UBS Global Life Sciences Conference
4. Touching 418 Billion Lives, Hepatitis Still Presents Significant Threat to Global Health
5. Touching 418 Million Lives, Hepatitis Still Presents Significant Threat to Global Health
6. Clinsys Clinical Research, Inc. Announces Key Hires, Rajagopalan Srinivasan, Ph.D, to Strengthen Global Biostatistics Service Offering and Christopher Gregory, Ph.D, to Scientific Affairs
7. Jazz Pharmaceuticals to Present at UBS Global Life Sciences Conference
8. A Large-Scale Research Project by a Dutch Consortium Addressing a Global Problem
9. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
10. Allos Therapeutics to Present at the 2007 UBS Global Life Sciences Conference
11. Merrill Lynch Global Pharmaceutical, Biotech and Medtech Conference to Webcast Millennium Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology Technology:Dendreon Appoints Hans Bishop as Chief Operating Officer 2Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years 2Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years 3New silicon-germanium nanowires could lead to smaller, more powerful electronic devices 2New silicon-germanium nanowires could lead to smaller, more powerful electronic devices 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 2Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 4Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 5Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 6